Why the Election Results Matter For 340B Hospitals
Ted Slafsky provides an insider’s perspective on where the 340B drug discount program is headed after the consequential midterm elections.
Medicaid, Drug Prices Could See Big Election Impacts
Nov. 7—On Tuesday, voters in three states approved expanding Medicaid eligibility to a total of more than 300,000 people.
FY 2019 IPPS/LTCH Final Rule
This document summarizes key provisions of the FY 2019 IPPS/LTCH final rule, published by CMS.
Hospitals Hit By 340B and Site-Neutral Medicare Cuts in New Rule
Nov. 5—Medicare pay cuts included in a new payment rule will affect the federal discount drug program and off-campus provider-based departments (PBDs).
Mixed News in Physician Payment Final Rule
Nov. 2—Leading physician advocacy groups are celebrating some provisions in the final rule issued by Medicare this week. But other components could cause problems.
Providers Should Keep Watch on Payer Discount Increases
A significant uptick in payer contractual allowances and discounts in the first quarter of 2018 indicate that hospitals should remain focused on payer mix and payer category shifts.
Nov. 5-9: Azar to Discuss Primary Care Amid Expectations of New Models
Nov. 1—Primary care will draw the attention of the Trump administration next week, amid the expectation that upcoming payment models will focus on that segment.
Physicians Want APM Changes to Slow—Contrary to Administration’s Plans
Oct. 30—Physicians across the country are concerned about rapid changes in alternative payment models (APMs) and want the process to slow down, according to a recent study. Meanwhile, Trump administration officials say physicians should prepare for accelerated changes.
Value-Focused Healthcare Strategy Must Be Multifaceted
Moving to a value-based payment model involves change and requires a strategy focused on both managing costs and enabling growth of the enterprise.
Why Your Access Strategy Demands Pricing Transparency
Consumers have come to expect price transparency in health care, which has greatly increased the strategic and operational importance of providers’ charge master descriptions and other pricing frameworks.